{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:35:12Z","timestamp":1770752112744,"version":"3.50.0"},"reference-count":42,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,9,15]]},"DOI":"10.2169\/internalmedicine.6721-20","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T22:06:48Z","timestamp":1616969208000},"page":"2939-2945","source":"Crossref","is-referenced-by-count":2,"title":["A Ruptured Jejunal Arterial Aneurysm in a Young Woman Undergoing Chronic Hemodialysis Due to Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis"],"prefix":"10.2169","volume":"60","author":[{"given":"Masataka","family":"Murakawa","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Kawagoe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Tomomitsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Odajima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Asakawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigoro","family":"Hirohama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michito","family":"Nagura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifuru","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Fujigaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65: 1-11, 2013.","DOI":"10.1007\/s10157-013-0869-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kamesh L, Harper L, Savage CO. ANCA-positive vasculitis. J Am Soc Nephrol 13: 1953-1960, 2002.","DOI":"10.1097\/01.ASN.0000016442.33680.3E"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wilde B, van Paassen P, Witzke O, Tervaert JWC. New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int 79: 599-612, 2011.","DOI":"10.1038\/ki.2010.472"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Han WK, Choi HK, Roth RM, McCluskey RT, Niles JL. Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int 63: 1079-1085, 2003.","DOI":"10.1046\/j.1523-1755.2003.00821.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yamaguchi M, Ando M, Kato S, et al. Increase of antimyeloperoxidase antineutrophil cytoplasmic antibody (ANCA) in patients with renal ANCA-associated vasculitis: association with risk to relapse. J Rheumatol 42: 1853-1860, 2015.","DOI":"10.3899\/jrheum.141622"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kemna MJ, Damoiseaux J, Austen J, et al. ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease. J Am Soc Nephrol 26: 537-542, 2015.","DOI":"10.1681\/ASN.2013111233"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Calatroni M, Oliva E, Gianfreda D, et al. ANCA-associated vasculitis in childhood: recent advances. Ital J Pediatr 43: 46, 2017.","DOI":"10.1186\/s13052-017-0364-x"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Haworth SJ, Pusey CD. Severe intestinal involvement in Wegener&apos;s granulomatosis. Gut 25: 1296-1300, 1984.","DOI":"10.1136\/gut.25.11.1296"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Srinivasan U, Coughlan RJ. Small intestinal perforation complicating Wegener&apos;s granulomatosis. Rheumatology (Oxford) 38: 289-290, 1999.","DOI":"10.1093\/rheumatology\/38.3.289"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gayraud M, Guillevin L, le Toumelin P, et al.; French Vasculitis Study Group. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 44: 666-675, 2001.","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 7: 238-258, 1998.","DOI":"10.1191\/096120398678920055"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mahr A, Katsahian S, Varet H, et al.; French Vasculitis Study Group (FVSG) and the European Vasculitis Society (EUVAS). Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis 72: 1003-1010, 2013.","DOI":"10.1136\/annrheumdis-2012-201750"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Eriksson P, Segelmark M, Hallb\u00f6\u00f6k O. Frequency, diagnosis, treatment, and outcome of gastrointestinal disease in granulomatosis with polyangiitis and microscopic polyangiitis. J Rheumatol 45: 529-537, 2018.","DOI":"10.3899\/jrheum.170249"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. De Virgilio A, Greco A, Magliulo G, et al. Polyarteritis nodosa: a contemporary overview. Autoimmun Rev 15: 564-570, 2016.","DOI":"10.1016\/j.autrev.2016.02.015"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bagai S, Sharma A, Gupta R, et al. Gastrointestinal involvement in granulomatosis with polyangiitis: case report and review. Indian J Nephrol 29: 415-418, 2019.","DOI":"10.4103\/ijn.IJN_141_18"},{"key":"16","unstructured":"16. Kirkland GS, Savige J, Wilson D, Heale W, Sinclair RA, Hope RN. Classical polyarteritis nodosa and microscopic polyarteritis with medium vessel involvement--a comparison of the clinical and laboratory features. Clin Nephrol 47: 176-180, 1997."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Aoki N, Soma K, Owada T, Ishii H. Wegener&apos;s granulomatosis complicated by arterial aneurysm. Intern Med 34: 790-793, 1995.","DOI":"10.2169\/internalmedicine.34.790"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kurata A, Nishimura Y, Yamato T, et al. Systemic granulomatous necrotizing vasculitis in a MPO-ANCA-positive patient. Pathol Int 54: 636-640, 2004.","DOI":"10.1111\/j.1440-1827.2004.01674.x"},{"key":"19","unstructured":"19. Dutton-Gaddis JG, Oyekan TB, Haraway GD, Crapse FJ. Middle colic artery rupture in a patient with ANCA associated vasculitis: a case report. J Okla State Med Assoc 97: 364-366, 2004."},{"key":"20","unstructured":"20. Inaguma D, Kurata K, Ishihara S, Machida H, Yaomura T, Kumon S. [A case of MPO-ANCA-related vasculitis that recurred as gastrointestinal bleeding and presented difficulty in treatment]. Nihon Jinzo Gakkai Shi 40: 560-565, 1998 (in Japanese)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ueda S, Matsumoto M, Ahn T, et al. Microscopic polyangiitis complicated with massive intestinal bleeding. J Gastroenterol 36: 264-270, 2001.","DOI":"10.1007\/s005350170114"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ravanan R, Weale AR, Lear PA, Thornton MJ, Kamel D, Tomson CR. Hemoperitoneum in a patient with ANCA-associated polyangiitis syndrome. Am J Kidney Dis 44: 908-911, 2004.","DOI":"10.1016\/S0272-6386(04)01097-2"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yahata K, Okamoto C, Imamaki H, et al. Fatal hemoperitoneum due to rupture of the left gastric artery in a patient with microscopic polyangiitis. Clin Exp Nephrol 13: 512-517, 2009.","DOI":"10.1007\/s10157-009-0182-6"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ito Y, Tanaka A, Sugiura Y, Sezaki R. An autopsy case of intraabdominal hemorrhage in microscopic polyangiitis. Intern Med 50: 1501-1502, 2011.","DOI":"10.2169\/internalmedicine.50.5549"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Li L, Li X, Fu P, Liu F. Recurrent gastrointestinal bleeding with ANCA associated glomerulonephritis successfully treated by transarterial embolization. Pak J Med Sci 29: 1465-1467, 2013.","DOI":"10.12669\/pjms.296.3669"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Muray Cases S, Andreu Mu\u00f1oz A, Cabezuelo Romero JB. Glomerulonephritis secondary to a microscopic polyangiitis complicated by rupture of a left gastric artery aneurysm. Med Clin (Barc) 148: 383-384, 2017.","DOI":"10.1016\/j.medcle.2017.01.020"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192, 1994.","DOI":"10.1002\/art.1780370206"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kim PH, Tsauo J, Shin JH, Yun SC. Transcatheter arterial embolization of gastrointestinal bleeding with N-Butyl cyanoacrylate: a systematic review and meta-analysis of safety and efficacy. J Vasc Interv Radiol 28: 522-531, 2017.","DOI":"10.1016\/j.jvir.2016.12.1220"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Geetha D, Jefferson JA. ANCA-associated vasculitis: core curriculum 2020. Am J Kidney Dis 75: 124-137, 2020.","DOI":"10.1053\/j.ajkd.2019.04.031"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Tervaert JW, van der Woude FJ, Fauci AS, et al. Association between active Wegener&apos;s granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149: 2461-2465, 1989.","DOI":"10.1001\/archinte.149.11.2461"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Boomsma MM, Stegeman CA, van der Leij MJ, et al. Prediction of relapses in Wegener&apos;s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 43: 2025-2033, 2000.","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Thai LH, Charles P, Resche-Rigon M, Desseaux K, Guillevin L. Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener&apos;s) relapses? Results of a retrospective study on 126 patients. Autoimmun Rev 13: 313-318, 2014.","DOI":"10.1016\/j.autrev.2013.11.003"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Miyabe Y, Karasawa K, Takabe T, et al. Long-term follow-up characteristics of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) receiving chronic hemodialysis at a single center. Clin Exp Nephrol 24: 136-142, 2020.","DOI":"10.1007\/s10157-019-01799-2"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Walsh M, Merkel PA, Mahr A, Jayne D. Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis. Arthritis Care Res (Hoboken) 62: 1166-1173, 2010.","DOI":"10.1002\/acr.20176"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Wada T, Hara A, Arimura Y, Sada KE, Makino H; Research Group of Intractable Vasculitis, Ministry of Health, Labor, and Welfare of Japan. Risk factors associated with relapse in Japanese patients with microscopic polyangiitis. J Rheumatol 39: 545-551, 2012.","DOI":"10.3899\/jrheum.110705"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Walsh M, Flossmann O, Berden A, et al.; European Vasculitis Study Group. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 64: 542-548, 2012.","DOI":"10.1002\/art.33361"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Hara A, Wada T, Sada KE, et al.; Research Committee on Intractable Vasculitides, and the Strategic Study Group to Establish the Evidence for Intractable Vasculitis Guideline. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis in Japan: a Nationwide, Prospective Cohort Study. J Rheumatol 45: 521-528, 2018.","DOI":"10.3899\/jrheum.170508"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. McGregor JG, Hogan SL, Hu Y, Jennette CE, Falk RJ, Nachman PH. Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease. Clin J Am Soc Nephrol 7: 240-247, 2012.","DOI":"10.2215\/CJN.05610611"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66: 222-227, 2007.","DOI":"10.1136\/ard.2006.054593"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Lionaki S, Hogan SL, Jennette CE, et al. The clinical course of ANCA small-vessel vasculitis on chronic dialysis. Kidney Int 76: 644-651, 2009.","DOI":"10.1038\/ki.2009.218"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Moiseev S, Novikov P, Jayne D, Mukhin N. End-stage renal disease in ANCA-associated vasculitis. Nephrol Dial Transplant 32: 248-253, 2017.","DOI":"10.1093\/ndt\/gfw046"},{"key":"42","unstructured":"42. Isobe M, Amano K, Arimura Y, et al.; JCS Joint Working Group. JCS 2017 guideline on management of vasculitis syndrome - digest version. Circ J 84: 299-359, 2020."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/18\/60_6721-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T03:18:46Z","timestamp":1631935126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/18\/60_6721-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":42,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6721-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"article-number":"6721-20"}}